Paul Knight
Stock Analyst at Keybanc
(2.39)
# 2,454
Out of 4,944 analysts
135
Total ratings
46.43%
Success rate
-2.25%
Average return
Main Sectors:
Stocks Rated by Paul Knight
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYRX Cryoport | Upgrades: Overweight | $15 | $9.08 | +65.20% | 9 | Aug 6, 2025 | |
| XGN Exagen | Upgrades: Overweight | $17 | $9.71 | +75.08% | 6 | Jul 30, 2025 | |
| EHC Encompass Health | Maintains: Overweight | $122 → $135 | $119.13 | +13.32% | 1 | May 27, 2025 | |
| HBIO Harvard Bioscience | Downgrades: Sector Weight | n/a | $0.50 | - | 5 | Apr 9, 2025 | |
| TECH Bio-Techne | Downgrades: Sector Weight | n/a | $54.71 | - | 9 | Apr 9, 2025 | |
| WAT Waters | Upgrades: Overweight | $460 | $296.83 | +54.97% | 5 | Mar 31, 2025 | |
| LAB Standard BioTools | Downgrades: Sector Weight | n/a | $1.31 | - | 2 | Feb 27, 2025 | |
| WST West Pharmaceutical Services | Maintains: Overweight | $470 → $325 | $246.22 | +32.00% | 11 | Feb 14, 2025 | |
| RPID Rapid Micro Biosystems | Initiates: Overweight | $8 | $2.91 | +174.91% | 1 | Feb 12, 2025 | |
| RVTY Revvity | Maintains: Overweight | $132 → $145 | $90.93 | +59.46% | 3 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $420 | $200.49 | +109.49% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $213 → $230 | $106.48 | +116.00% | 1 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $33 | $25.68 | +28.50% | 5 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $28 → $36 | $19.41 | +85.47% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $310 | $209.14 | +48.23% | 9 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $210 → $220 | $127.15 | +73.02% | 7 | Feb 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $484.79 | - | 6 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $35 → $37 | $22.36 | +65.47% | 5 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $2.75 | - | 8 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $4.88 | - | 1 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $120.29 | - | 8 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Weight | n/a | $32.09 | - | 3 | May 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $51 → $40 | $13.07 | +206.04% | 6 | Sep 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $390 → $300 | $155.00 | +93.55% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $290 → $250 | $190.23 | +31.42% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $382 → $441 | $122.92 | +258.77% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $222 → $236 | $114.13 | +106.78% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $92 → $99 | $74.27 | +33.30% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $55 | $10.75 | +411.63% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $30.68 | - | 4 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Weight | n/a | $69.13 | - | 1 | Nov 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | n/a | $101.11 | - | 5 | Oct 23, 2017 |
Cryoport
Aug 6, 2025
Upgrades: Overweight
Price Target: $15
Current: $9.08
Upside: +65.20%
Exagen
Jul 30, 2025
Upgrades: Overweight
Price Target: $17
Current: $9.71
Upside: +75.08%
Encompass Health
May 27, 2025
Maintains: Overweight
Price Target: $122 → $135
Current: $119.13
Upside: +13.32%
Harvard Bioscience
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $0.50
Upside: -
Bio-Techne
Apr 9, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $54.71
Upside: -
Waters
Mar 31, 2025
Upgrades: Overweight
Price Target: $460
Current: $296.83
Upside: +54.97%
Standard BioTools
Feb 27, 2025
Downgrades: Sector Weight
Price Target: n/a
Current: $1.31
Upside: -
West Pharmaceutical Services
Feb 14, 2025
Maintains: Overweight
Price Target: $470 → $325
Current: $246.22
Upside: +32.00%
Rapid Micro Biosystems
Feb 12, 2025
Initiates: Overweight
Price Target: $8
Current: $2.91
Upside: +174.91%
Revvity
Feb 3, 2025
Maintains: Overweight
Price Target: $132 → $145
Current: $90.93
Upside: +59.46%
Jan 23, 2025
Maintains: Overweight
Price Target: $400 → $420
Current: $200.49
Upside: +109.49%
Jan 23, 2025
Maintains: Overweight
Price Target: $213 → $230
Current: $106.48
Upside: +116.00%
Dec 13, 2024
Maintains: Overweight
Price Target: $30 → $33
Current: $25.68
Upside: +28.50%
Nov 5, 2024
Maintains: Overweight
Price Target: $28 → $36
Current: $19.41
Upside: +85.47%
Oct 23, 2024
Maintains: Overweight
Price Target: $290 → $310
Current: $209.14
Upside: +48.23%
Feb 15, 2024
Maintains: Overweight
Price Target: $210 → $220
Current: $127.15
Upside: +73.02%
Oct 26, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $484.79
Upside: -
Aug 30, 2023
Maintains: Overweight
Price Target: $35 → $37
Current: $22.36
Upside: +65.47%
Aug 8, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $2.75
Upside: -
Jul 12, 2023
Initiates: Sector Weight
Price Target: n/a
Current: $4.88
Upside: -
May 24, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $120.29
Upside: -
May 10, 2023
Downgrades: Sector Weight
Price Target: n/a
Current: $32.09
Upside: -
Sep 15, 2022
Maintains: Overweight
Price Target: $51 → $40
Current: $13.07
Upside: +206.04%
May 5, 2022
Maintains: Overweight
Price Target: $390 → $300
Current: $155.00
Upside: +93.55%
Apr 28, 2022
Maintains: Overweight
Price Target: $290 → $250
Current: $190.23
Upside: +31.42%
Jan 8, 2021
Maintains: Overweight
Price Target: $382 → $441
Current: $122.92
Upside: +258.77%
Jan 8, 2021
Maintains: Overweight
Price Target: $222 → $236
Current: $114.13
Upside: +106.78%
Jan 8, 2021
Maintains: Overweight
Price Target: $92 → $99
Current: $74.27
Upside: +33.30%
Jan 8, 2021
Maintains: Overweight
Price Target: $47 → $55
Current: $10.75
Upside: +411.63%
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $30.68
Upside: -
Nov 10, 2020
Initiates: Sector Weight
Price Target: n/a
Current: $69.13
Upside: -
Oct 23, 2017
Upgrades: Neutral
Price Target: n/a
Current: $101.11
Upside: -